|Rapid molecular detection of tuberculosis and rifampin resistance|
CC Boehme, P Nabeta, D Hillemann, MP Nicol, S Shenai, F Krapp, ...
New England Journal of Medicine 363 (11), 1005-1015, 2010
|The diarylquinoline TMC207 for multidrug-resistant tuberculosis|
AH Diacon, A Pym, M Grobusch, R Patientia, R Rustomjee, L Page-Shipp, ...
New England Journal of Medicine 360 (23), 2397-2405, 2009
|A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis|
R Rustomjee, C Lienhardt, T Kanyok, GR Davies, J Levin, T Mthiyane, ...
The international journal of tuberculosis and lung disease 12 (2), 128-138, 2008
|A four-month gatifloxacin-containing regimen for treating tuberculosis|
CS Merle, K Fielding, OB Sow, M Gninafon, MB Lo, T Mthiyane, ...
New England Journal of Medicine 371 (17), 1588-1598, 2014
|Early bactericidal activity and pharmacokinetics of the diarylquinoline TMC207 in treatment of pulmonary tuberculosis|
R Rustomjee, AH Diacon, J Allen, A Venter, C Reddy, RF Patientia, ...
Antimicrobial agents and chemotherapy 52 (8), 2831-2835, 2008
|Tuberculosis—advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers|
RS Wallis, M Maeurer, P Mwaba, J Chakaya, R Rustomjee, GB Migliori, ...
The Lancet infectious diseases 16 (4), e34-e46, 2016
|Host-directed therapies for infectious diseases: current status, recent progress, and future prospects|
A Zumla, M Rao, RS Wallis, SHE Kaufmann, R Rustomjee, P Mwaba, ...
The Lancet Infectious Diseases 16 (4), e47-e63, 2016
|What we know about tuberculosis transmission: an overview|
G Churchyard, P Kim, NS Shah, R Rustomjee, N Gandhi, B Mathema, ...
The Journal of infectious diseases 216 (suppl_6), S629-S635, 2017
|Treatment of tuberculosis: present status and future prospects|
P Onyebujoh, A Zumla, I Ribeiro, R Rustomjee, P Mwaba, M Gomes, ...
Bulletin of the World Health Organization 83, 857-865, 2005
|The early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosis|
FA Sirgel, PB Fourie, PR Donald, N Padayatchi, R Rustomjee, J Levin, ...
American journal of respiratory and critical care medicine 172 (1), 128-135, 2005
|Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective …|
SG Mfinanga, BJ Kirenga, DM Chanda, B Mutayoba, T Mthiyane, G Yimer, ...
The Lancet infectious diseases 14 (7), 563-571, 2014
|Towards host-directed therapies for tuberculosis|
A Zumla, J Chakaya, M Hoelscher, F Ntoumi, R Rustomjee, C Vilaplana, ...
Nature reviews Drug discovery 14 (8), 511-512, 2015
|Reduced antituberculosis drug concentrations in HIV-infected patients who are men or have low weight: implications for international dosing guidelines|
H McIlleron, R Rustomjee, M Vahedi, T Mthiyane, P Denti, C Connolly, ...
Antimicrobial agents and chemotherapy 56 (6), 3232-3238, 2012
|Drivers of tuberculosis transmission|
B Mathema, JR Andrews, T Cohen, MW Borgdorff, M Behr, JR Glynn, ...
The Journal of infectious diseases 216 (suppl_6), S644-S653, 2017
|Effect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosis|
C Riou, B Perez Peixoto, L Roberts, K Ronacher, G Walzl, C Manca, ...
PloS one 7 (5), e36886, 2012
|A semimechanistic pharmacokinetic-enzyme turnover model for rifampin autoinduction in adult tuberculosis patients|
W Smythe, A Khandelwal, C Merle, R Rustomjee, M Gninafon, M Bocar Lo, ...
Antimicrobial agents and chemotherapy 56 (4), 2091-2098, 2012
|Use of a WHO-recommended algorithm to reduce mortality in seriously ill patients with HIV infection and smear-negative pulmonary tuberculosis in South Africa: an observational …|
TH Holtz, G Kabera, T Mthiyane, T Zingoni, S Nadesan, D Ross, J Allen, ...
The Lancet infectious diseases 11 (7), 533-540, 2011
|A randomized controlled trial of azithromycin versus doxycycline/ciprofloxacin for the syndromic management of sexually transmitted infections in a resource-poor setting|
R Rustomjee, ABM Kharsany, CA Connolly, SSA Karim
Journal of Antimicrobial Chemotherapy 49 (5), 875-878, 2002
|Phase 1 trial of nonoxynol-9 film among sex workers in South Africa|
R Rustomjee, QA Karim, SSA Karim, M Laga, Z Stein
Aids 13 (12), 1511-1515, 1999
|Model-based evaluation of higher doses of rifampin using a semimechanistic model incorporating autoinduction and saturation of hepatic extraction|
MT Chirehwa, R Rustomjee, T Mthiyane, P Onyebujoh, P Smith, ...
Antimicrobial agents and chemotherapy 60 (1), 487-494, 2015